Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

DSpace Repositorium (Manakin basiert)

Zur Kurzanzeige

dc.contributor.author Bitzer, Michael
dc.date.accessioned 2022-05-04T14:25:21Z
dc.date.available 2022-05-04T14:25:21Z
dc.date.issued 2021
dc.identifier.issn 2468-1253
dc.identifier.uri http://hdl.handle.net/10900/126553
dc.language.iso en en
dc.publisher Elsevier Inc de_DE
dc.relation.uri https://doi.org/10.1016/S2468-1253(21)00196-5
dc.subject.ddc 610 de_DE
dc.title Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study de_DE
dc.type Article de_DE
utue.quellen.id 20211125174918_00412
utue.publikation.seiten 803-815 de_DE
utue.personen.roh Javle, Milind
utue.personen.roh Roychowdhury, Sameek
utue.personen.roh Kelley, Robin Kate
utue.personen.roh Sadeghi, Saeed
utue.personen.roh Macarulla, Teresa
utue.personen.roh Weiss, Karl Heinz
utue.personen.roh Waldschmidt, Dirk-Thomas
utue.personen.roh Goyal, Lipika
utue.personen.roh Borbath, Ivan
utue.personen.roh El-Khoueiry, Anthony
utue.personen.roh Borad, Mitesh J.
utue.personen.roh Yong, Wei Peng
utue.personen.roh Philip, Philip A.
utue.personen.roh Bitzer, Michael
utue.personen.roh Tanasanvimon, Surbpong
utue.personen.roh Li, Ai
utue.personen.roh Pande, Amit
utue.personen.roh Soifer, Harris S.
utue.personen.roh Shepherd, Stacie Peacock
utue.personen.roh Moran, Susan
utue.personen.roh Zhu, Andrew X.
utue.personen.roh Bekaii-Saab, Tanios S.
utue.personen.roh Abou-Alfa, Ghassan K.
dcterms.isPartOf.ZSTitelID Lancet Gastroenterology & Hepatology de_DE
dcterms.isPartOf.ZS-Issue 10 de_DE
dcterms.isPartOf.ZS-Volume 6 de_DE
utue.fakultaet 04 Medizinische Fakultät


Dateien zu dieser Ressource

Dateien Größe Format Anzeige

Zu diesem Dokument gibt es keine Dateien.

Das Dokument erscheint in:

Zur Kurzanzeige